Search Results

LINAVIB 5

LINAVIB 5

LINAGLIPTIN 5mg. IP

Send Enquiry

CURE

Tablets

Packaging and packing Type

Alu Alu | 10x10

MRP :

₹119

PTR :

₹85

PTS :

₹76.5

Belongs to a class of medications called dipeptidyl peptidase-4 [DPP-4] inhibitors that are primarily used in the management of type 2 diabetes. A po... Read More

Composition

LINAGLIPTIN 5mg. IP

Send Enquiry

India’s Largest Pharma Franchise

100%

Genuine Products

Secure

Payments

24 x 7

Customer Support

About the product

Description

Belongs to a class of medications called dipeptidyl peptidase-4 [DPP-4] inhibitors that are primarily used in the management of type 2 diabetes. A potent antihyperglycaemic agent that shows highly selective, potent, dose-dependent inhibition of DPP-4, with ≥ 80% inhibition of DPP-4 throughout the 24-hour dosing interval. (Scott, 2011) An efficient and well-tolerated treatment choice for individuals with type 2 diabetes, including those experiencing renal impairment for whom other antihyperglycemic agents require a dosage adjustment or are not suitable. (Deeks, 2012) Significantly improves glucose control without causing weight gain or increasing the risk of hypoglycemia. (Fumiko Yamamoto, 2020) More efficacious than voglibose 0.2 mg in terms of improving glycaemic control in patients with type 2 diabetes. (Scott, 2011) Displays higher potency and long duration of DPP-4 inhibition compared to other DPP-4 inhibitors. (Manash P. Baruah, 2016) Slows the inactivation of the endogenous incretin hormones and reduces blood glucose levels. (Aronson, 2012) Provides significant decreases in hemoglobin A (1c) levels, along with reductions in fasting and post-meal blood sugar levels among individuals diagnosed with type 2 diabetes mellitus. (Neumiller, 2012) Produces a significant, clinically meaningful, and sustained improvement in glycaemic control along with improvements in β-cell function parameters. (S Del Prato, 2011) An efficacious, safe, and well-tolerated drug in patients with T2DM and various degrees of renal impairment. (Chu-qing Cao, 2015) A safe and effective treatment for patients unable to take metformin due to either renal impairment or intolerance. (Chu-qing Cao, 2015) A valuable treatment option for individuals diagnosed with type 2 diabetes irrespective of race or ethnic background. (Akiko Sarashina, 2016)

Side Effects

Diarrhea, Decreased appetite, Nausea, Vomiting, Itching

Indication

Type 2 diabetes mellitus

Important Notice

Temp data

Storage Condition

Product details for storage condition Product details for storage condition Product details for storage condition Product details for storage condition

Similar Products

No products found.

Looking into the future of healthcare

Contact

Plot No 4, HSIIDC IT PARK, Sector 22,Panchkula, Haryana, India 134109

Phone: 9888988858

Business Hours

Mon-Sat: 9AM to 6PM

Franchise Enquiry

Request a callback to get more information about becoming a PCD Franchise Owner***

    Send Enquiry

    Request a callback to get more information about becoming a PCD Franchise Owner